Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2005

Open Access 01-12-2005 | Research article

The morbidity and mortality following a diagnosis of peripheral arterial disease: Long-term follow-up of a large database

Authors: Jaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, Irina Proskorovsky

Published in: BMC Cardiovascular Disorders | Issue 1/2005

Login to get access

Abstract

Background

Awareness of the significance of peripheral arterial disease is increasing, but quantitative estimates of the ensuing burden and the impact of other risk factors remains limited. The objective of this study was to fill this need.

Methods

Morbidity and mortality were examined in 16,440 index patients diagnosed with peripheral arterial disease in Saskatchewan, Canada between 1985 and 1995. Medical history and patient characteristics were available retrospectively to January 1980 and follow-up was complete to March 1998. Crude and adjusted event rates were calculated and Kaplan-Meier survival curves estimated. Cox proportional hazards analyses were conducted to examine the effect of risk factors on these rates. Patients suffering a myocardial infarction or ischemic stroke in Saskatchewan provided two reference populations.

Results

Half of the index patients were male; the majority was over age 65; 73% had at least one additional risk factor at index diagnosis; 10% suffered a subsequent stroke, another 10% a myocardial infarction, and 49% died within the mean follow-up of 5.9 years. Annual mortality (8.2%) was higher among patients with PAD than after a myocardial infarction (6.3%) but slightly lower than that in patients suffering a stroke (11.3%). Index patients with comorbid disease (e.g., diabetes) were at highest risk of death and other events.

Conclusion

A diagnosis of peripheral arterial disease is critical evidence of more widespread atherothrombotic disease, with substantial risks of subsequent cardiovascular events and death. Given that the majority has additional comorbidities, these risks are further increased.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stoffers HE, Rinkens RP, Kester AD, Kaiser V, Knottnerus JA: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996, 25: 282-290.CrossRefPubMed Stoffers HE, Rinkens RP, Kester AD, Kaiser V, Knottnerus JA: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996, 25: 282-290.CrossRefPubMed
2.
go back to reference Selvin E, Erlinger TP: Prevalence and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004, 110: 738-743.CrossRefPubMed Selvin E, Erlinger TP: Prevalence and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004, 110: 738-743.CrossRefPubMed
3.
go back to reference Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001, 286: 1317-1324.CrossRefPubMed Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001, 286: 1317-1324.CrossRefPubMed
4.
go back to reference Criqui MH: Systematic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol. 2001, 88 (suppl 2): 43-47.CrossRef Criqui MH: Systematic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol. 2001, 88 (suppl 2): 43-47.CrossRef
5.
go back to reference Weitz JI, Byrne J, Clagett P, Farkouh ME, Porter JM, Sackett DL, Strandness DE, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation. 1996, 94: 3026-3049.CrossRefPubMed Weitz JI, Byrne J, Clagett P, Farkouh ME, Porter JM, Sackett DL, Strandness DE, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation. 1996, 94: 3026-3049.CrossRefPubMed
6.
go back to reference Criqui MH: Peripheral arterial disease – epidemiological aspects. Vasc Med. 2001, 3-7. 6(suppl1) Criqui MH: Peripheral arterial disease – epidemiological aspects. Vasc Med. 2001, 3-7. 6(suppl1)
7.
go back to reference Price PF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease. Eur Heart J. 1999, 20: 344-353.CrossRefPubMed Price PF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease. Eur Heart J. 1999, 20: 344-353.CrossRefPubMed
8.
go back to reference McDermott MM, Greenland P, Liu K, Guralnik JM, Crique MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ: Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA. 2001, 286: 1599-1606.CrossRefPubMed McDermott MM, Greenland P, Liu K, Guralnik JM, Crique MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ: Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA. 2001, 286: 1599-1606.CrossRefPubMed
9.
go back to reference Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van Ree JW, Knottnerus JA: Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998, 16: 177-182.CrossRefPubMed Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van Ree JW, Knottnerus JA: Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998, 16: 177-182.CrossRefPubMed
10.
go back to reference Fowkes F, Housley E, Cawood EH, MacIntyre CC, Ruckley CV, Prescott RJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991, 20: 384-392.CrossRefPubMed Fowkes F, Housley E, Cawood EH, MacIntyre CC, Ruckley CV, Prescott RJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991, 20: 384-392.CrossRefPubMed
11.
go back to reference Newman AB: Peripheral arterial disease: Insights from population studies of older adults. J Am Geriatr Soc. 2000, 48: 1157-1162.CrossRefPubMed Newman AB: Peripheral arterial disease: Insights from population studies of older adults. J Am Geriatr Soc. 2000, 48: 1157-1162.CrossRefPubMed
12.
go back to reference Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J: Health Databases in Saskatchewan. Pharmacoepidemiology. Edited by: Strom BL. 2000, Chichester: Wiley, 325-345. ThirdCrossRef Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J: Health Databases in Saskatchewan. Pharmacoepidemiology. Edited by: Strom BL. 2000, Chichester: Wiley, 325-345. ThirdCrossRef
13.
go back to reference Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA: Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease. Arch Intern Med. 1992, 152: 1220-1224.CrossRefPubMed Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA: Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease. Arch Intern Med. 1992, 152: 1220-1224.CrossRefPubMed
14.
go back to reference Meijer WT, Grobbee DE, Hunink MGM, Hofman A, Hoes AW: Determinants of peripheral arterial disease in the elderly: The Rotterdam Study. Arch Intern Med. 2000, 160: 2934-2938.CrossRefPubMed Meijer WT, Grobbee DE, Hunink MGM, Hofman A, Hoes AW: Determinants of peripheral arterial disease in the elderly: The Rotterdam Study. Arch Intern Med. 2000, 160: 2934-2938.CrossRefPubMed
15.
go back to reference Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Yaari S, Goldbourt U: Intermittent claudication in 8343 men and 21-year specific mortality follow-up. Ann Epidemiol. 1997, 7: 180-187.CrossRefPubMed Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Yaari S, Goldbourt U: Intermittent claudication in 8343 men and 21-year specific mortality follow-up. Ann Epidemiol. 1997, 7: 180-187.CrossRefPubMed
16.
go back to reference Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001, 344: 1608-1621.CrossRefPubMed Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001, 344: 1608-1621.CrossRefPubMed
17.
go back to reference Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS: Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: A six-year follow-up study. J Vasc Surg. 1989, 9: 691-697.CrossRefPubMed Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS: Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: A six-year follow-up study. J Vasc Surg. 1989, 9: 691-697.CrossRefPubMed
18.
go back to reference Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992, 326: 381-386.CrossRefPubMed Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992, 326: 381-386.CrossRefPubMed
19.
go back to reference Conway DSG, Lip GYH: Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). Am J Cardiol. 2004, 93: 1422-1425.CrossRefPubMed Conway DSG, Lip GYH: Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). Am J Cardiol. 2004, 93: 1422-1425.CrossRefPubMed
20.
go back to reference McDermott MM, Mehta S, Ahn H, Greenland P: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997, 12: 209-215.CrossRefPubMedPubMedCentral McDermott MM, Mehta S, Ahn H, Greenland P: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997, 12: 209-215.CrossRefPubMedPubMedCentral
Metadata
Title
The morbidity and mortality following a diagnosis of peripheral arterial disease: Long-term follow-up of a large database
Authors
Jaime Caro
Kristen Migliaccio-Walle
Khajak J Ishak
Irina Proskorovsky
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2005
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-5-14

Other articles of this Issue 1/2005

BMC Cardiovascular Disorders 1/2005 Go to the issue